Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5199274
Max Phase: Preclinical
Molecular Formula: C37H63N13O8S2
Molecular Weight: 882.13
Associated Items:
ID: ALA5199274
Max Phase: Preclinical
Molecular Formula: C37H63N13O8S2
Molecular Weight: 882.13
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CSSCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C37H63N13O8S2/c1-21(2)18-27(35(57)58)48-32(54)28(20-60-59-17-13-38)49-31(53)26(19-22-9-11-23(51)12-10-22)47-33(55)29-8-5-16-50(29)34(56)25(7-4-15-45-37(42)43)46-30(52)24(39)6-3-14-44-36(40)41/h9-12,21,24-29,51H,3-8,13-20,38-39H2,1-2H3,(H,46,52)(H,47,55)(H,48,54)(H,49,53)(H,57,58)(H4,40,41,44)(H4,42,43,45)/t24-,25-,26-,27-,28-,29-/m0/s1
Standard InChI Key: WJHYZVLIJGURQS-AQRCPPRCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 882.13 | Molecular Weight (Monoisotopic): 881.4364 | AlogP: -1.81 | #Rotatable Bonds: 27 |
Polar Surface Area: 370.08 | Molecular Species: ZWITTERION | HBA: 13 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 18 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.77 | CX Basic pKa: 11.65 | CX LogP: -6.54 | CX LogD: -9.40 |
Aromatic Rings: 1 | Heavy Atoms: 60 | QED Weighted: 0.02 | Np Likeness Score: 0.21 |
1. Einsiedel J, Schmidt MF, Hübner H, Gmeiner P.. (2022) Development of disulfide-functionalized peptides covalently binding G protein-coupled receptors., 61 [PMID:35334449] [10.1016/j.bmc.2022.116720] |
Source(1):